Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Synchrony Financial Director's Dealing 2021

Mar 3, 2021

30169_dirs_2021-03-03_b73b7d12-fe38-4d88-bfde-56ba2ac2c0c3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Synchrony Financial (SYF)
CIK: 0001601712
Period of Report: 2021-03-01

Reporting Person: Whynott Paul (See remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-01 Common Stock A 14063 $40 Acquired 84525 Direct
2021-03-01 Common Stock F 5618 $40 Disposed 78907 Direct
2021-03-01 Common Stock M 2669 $24.55 Acquired 81576 Direct
2021-03-01 Common Stock S 2669 $39.46 Disposed 78907 Direct
2021-03-01 Common Stock S 11959 $39.80 Disposed 66948 Direct
2021-03-02 Common Stock S 5852 $39.83 Disposed 61096 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-01 Employee Stock Option (right to buy) $24.55 M 2669 Disposed 2024-09-17 Common Stock (2669.0) Direct

Footnotes

F1: Represents restricted stock units that will vest in three equal annual installments of 33.33% each, beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial (the "Company") common stock.

F2: Reflects the number of shares of Company common stock automatically withheld by the Company to pay the tax liability of the Reporting Person in connection with the vesting of restricted stock units. No investment decision was made by the Reporting Person in connection with the withholding.

F3: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 29, 2021.

F4: This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.46 to $40.09. Information regarding the number of shares sold at each price will be provided upon request.

F5: The reporting person was awarded employee stock options on September 17, 2014, which vested in five equal annual installments of 20% each, beginning on the first anniversary of the grant date.